CODX buy NOW around 1.1usd - PUMP and DUMP - go to the MOON
BUY CODX = 1.1$
STOP=0.7$
TARGET1=2.9$ R=4
TARGET2=3.8$ R=7
TARGET3=5.1$ R=10
Chart 1 month big big level and base = 0.8$ to 1.1$
NEXT level 3.0$ usd
CODX is setting up to be a major player in the extremely “Profitable” 100Bil Biotechnology sector focusing on “Cancer Detection” using its patented CoPrimer™ technology with applications in Liquid Biopsy and companion diagnostic tests.
CODX just announced exciting news of favorable results on a study to detect cancer mutations using its patented CoPrimer™ technology, with applications in liquid biopsy and companion diagnostic tests.
Co-Diagnostics Disrupting Multi-Billion Dollar Biotech Sector With State-Of-The-Art Patented CoPrimers Providing High-Performance Detection of Cancer Mutations in Liquid Biopsy Samples Co-Diagnostics Inc. looks to be moving forward in a record-breaking pace...
I believe at just $1.10 this NASDAQ biotech stock is seriously undervalued.
Look at one of CODX biggest rivals biotech Giant Illumina it trades at $286 dollars per share, another rival to look at is Myriad Genetics it trades at $25 dollars per share.
One of CODX biggest rivals is likely biotech giant Illumina which is a “Cancer Detection Stock.” Illumina trades at $286 dollars per share, and drew over 100Mil from Bill Gates, Jeff Bezos and others to launch Grail.
CODX buy NOW around 1.1usd - PUMP and DUMP - go to the MOON
STOP=0.7$
TARGET1=2.9$ R=4
TARGET2=3.8$ R=7
TARGET3=5.1$ R=10
Chart 1 month big big level and base = 0.8$ to 1.1$
NEXT level 3.0$ usd
CODX is setting up to be a major player in the extremely “Profitable” 100Bil Biotechnology sector focusing on “Cancer Detection” using its patented CoPrimer™ technology with applications in Liquid Biopsy and companion diagnostic tests.
CODX just announced exciting news of favorable results on a study to detect cancer mutations using its patented CoPrimer™ technology, with applications in liquid biopsy and companion diagnostic tests.
Co-Diagnostics Disrupting Multi-Billion Dollar Biotech Sector With State-Of-The-Art Patented CoPrimers Providing High-Performance Detection of Cancer Mutations in Liquid Biopsy Samples Co-Diagnostics Inc. looks to be moving forward in a record-breaking pace...
I believe at just $1.10 this NASDAQ biotech stock is seriously undervalued.
Look at one of CODX biggest rivals biotech Giant Illumina it trades at $286 dollars per share, another rival to look at is Myriad Genetics it trades at $25 dollars per share.
One of CODX biggest rivals is likely biotech giant Illumina which is a “Cancer Detection Stock.” Illumina trades at $286 dollars per share, and drew over 100Mil from Bill Gates, Jeff Bezos and others to launch Grail.
CODX buy NOW around 1.1usd - PUMP and DUMP - go to the MOON
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.